The Food and Drug Administration 1st authorised the injectable medication for managing diabetes in 2017; the agency authorized a drug with an increased dose with the active component in copyright, termed semaglutide, to deal with obesity in 2021, beneath the manufacturer title Wegovy. Because then, speak of the drug has https://michaelg135brf4.frewwebs.com/profile